Generic placeholder image

Current Molecular Medicine

Editor-in-Chief

ISSN (Print): 1566-5240
ISSN (Online): 1875-5666

Research Article

The Marine Factor 3,5-dihydroxy-4-methoxybenzyl Alcohol Suppresses Cell Growth, Inflammatory Cytokine Production, and NF-κB Signaling-enhanced Osteoclastogenesis in In vitro Mouse Macrophages RAW264.7 Cells

Author(s): Masayoshi Yamaguchi*, Kenji Yoshiike, Hideaki Watanabe and Mitsugu Watanabe

Volume 24, Issue 6, 2024

Published on: 13 July, 2023

Page: [813 - 825] Pages: 13

DOI: 10.2174/1566524023666230626141519

Price: $65

conference banner
Abstract

Background and objective: The novel marine factor 3,5-dihydroxy-4- methoxybenzyl alcohol (DHMBA) was originally identified in the Pacific oyster Crassostrea Gigas. DHMBA has been shown to prevent oxidative stress by scavenging radicals and enhance the production of antioxidant proteins. However, the pharmacologic role of DHMBA has been poorly understood. Inflammation is implicated in the pathogenesis of many diseases. Inflammatory cytokines are produced in macrophages with stimulation of lipopolysaccharide (LPS) and are used as biomarkers that cause diverse disease conditions. Therefore, this study has been undertaken to elucidate whether DHMBA expresses anti-inflammatory effects in in vitro mouse macrophage RAW264.7 cells.

Methods: Mouse macrophage RAW264.7 cells were cultured in a medium containing 10% fetal bovine serum (FBS) with or without DHMBA (1-1000 μM).

Results: Culturing with DHMBA (1-1000 μM) suppressed the growth and stimulated the death of RAW264.7 cells in vitro, leading to a decrease in cell number. Treatment with DHMBA reduced the levels of Ras, PI3K, Akt, MAPK, phospho-MAPK, and mTOR, which are signalling factors to promote cell proliferation, and it raised the levels of p53, p21, Rb, and regucalcin, which are cell growth suppressors. DHMBA treatment elevated caspase-3 and cleaved caspase-3 levels. Interestingly, DHMBA treatment repressed the production of inflammatory cytokines, including tumor necrosis factor-α, interleukin-6, interleukin-1β, or prostaglandin E2, which were enhanced by LPS stimulation. Notably, the levels of NF-κB p65 were increased by LPS treatment, and this augmentation was repres-sed by DHMBA treatment. Moreover, LPS treatment stimulated osteoclastogenesis of RAW264.7 cells. This stimulation was blocked by DHMBA treatment, and this effect was not caused by the presence of an NF-κB signalling inhibitor.

Conclusion: DHMBA was found to potentially suppress the activity of inflammatory macrophages in vitro, suggesting its therapeutic usefulness in inflammatory conditions.

« Previous
[1]
Abdelhamid RE, Sluka KA. ASICs mediate pain and inflammation in musculoskeletal diseases. Physiology 2015; 30(6): 449-59.
[http://dx.doi.org/10.1152/physiol.00030.2015] [PMID: 26525344]
[2]
Berenbaum F. Osteoarthritis as an inflammatory disease (osteoarthritis is not osteoarthrosis!). Osteoarthritis Cartilage 2013; 21(1): 16-21.
[http://dx.doi.org/10.1016/j.joca.2012.11.012] [PMID: 23194896]
[3]
Pomari E, Stefanon B, Colitti M. Effect of plant extracts on H2O2-induced inflammatory gene expression in macrophages. J Inflamm Res 2014; 7: 103-12.
[http://dx.doi.org/10.2147/JIR.S61471] [PMID: 25075197]
[4]
Kong L, Smith W, Hao D. Overview of RAW264.7 for osteoclastogensis study: Phenotype and stimuli. J Cell Mol Med 2019; 23(5): 3077-87.
[http://dx.doi.org/10.1111/jcmm.14277] [PMID: 30892789]
[5]
Yamaguchi M, Levy RM. Metaxalone suppresses production of inflammatory cytokines associated with painful conditions in mouse macrophages RAW264.7 cells in vitro: Synergistic effect with β-caryophyllene. Curr Mol Med 2020; 20(8): 643-52.
[http://dx.doi.org/10.2174/1566524020666200217102508] [PMID: 32065089]
[6]
Xu Y, Wang X, Liu L, Wang J, Wu J, Sun C. Role of macrophages in tumor progression and therapy (Review). Int J Oncol 2022; 60(5): 57-75.
[http://dx.doi.org/10.3892/ijo.2022.5347] [PMID: 35362544]
[7]
Geindreau M, Bruchard M, Vegran F. Role of cytokines and chemokines in angiogenesis in a tumor context. Cancers 2022; 14(10): 2446.
[http://dx.doi.org/10.3390/cancers14102446] [PMID: 35626056]
[8]
Hartley JW, Evans LH, Green KY, et al. Expression of infectious murine leukemia viruses by RAW264.7 cells, a potential complication for studies with a widely used mouse macrophage cell line. Retrovirology 2008; 5(1): 1.
[http://dx.doi.org/10.1186/1742-4690-5-1] [PMID: 18177500]
[9]
Li Y, Zhang J, Yan C, et al. Martin prevented LPS-induced osteoclastogenesis by regulating the NF-κB pathway in vitro. J Microbiol Biotechnol 2022; 32(2): 141-8.
[http://dx.doi.org/10.4014/jmb.2109.09033] [PMID: 35001005]
[10]
Maldonado RF, Sá-Correia I, Valvano MA. Lipopolysaccharide modification in Gram-negative bacteria during chronic infection. FEMS Microbiol Rev 2016; 40(4): 480-93.
[http://dx.doi.org/10.1093/femsre/fuw007] [PMID: 27075488]
[11]
Ohanian SH, Schwab JH. Persistence of group a streptococcal cell walls related to chronic inflammation of rabbit dermal connective tissue. J Exp Med 1967; 125(6): 1137-48.
[http://dx.doi.org/10.1084/jem.125.6.1137] [PMID: 5337778]
[12]
Watanabe M, Fuda H, Jin S, et al. Isolation and characterization of a phenolic antioxidant from the Pacific oyster (Crassostrea gigas). J Agric Food Chem 2012; 60(3): 830-5.
[http://dx.doi.org/10.1021/jf2038532] [PMID: 22224848]
[13]
Fuda H, Watanabe M, Hui SP, et al. Anti-apoptotic effects of novel phenolic antioxidant isolated from the Pacific oyster (Crassostrea gigas) on cultured human hepatocytes under oxidative stress. Food Chem 2015; 176: 226-33.
[http://dx.doi.org/10.1016/j.foodchem.2014.12.066] [PMID: 25624228]
[14]
Joko S, Watanabe M, Fuda H, et al. Comparison of chemical structures and cytoprotection abilities between direct and indirect antioxidants. J Funct Foods 2017; 35: 245-55.
[http://dx.doi.org/10.1016/j.jff.2017.05.039]
[15]
Tamano H, Shakushi Y, Watanabe M, et al. Preventive effect of 3,5-dihydroxy-4-methoxybenzyl alcohol (DHMBA) and zinc, components of the pacific oyster Crassostrea gigas, on glutamatergic neuron activity in the hippocampus. J Agric Food Chem 2019; 67: 12844-53.
[16]
Fukai M, Nakayabu T, Ohtani S, et al. The Phenolic Antioxidant 3,5-dihydroxy-4-methoxybenzyl Alcohol (DHMBA) prevents enterocyte cell death under oxygen-dissolving cold conditions through polyphyletic antioxidant actions. J Clin Med 2021; 10(9): 1972.
[http://dx.doi.org/10.3390/jcm10091972] [PMID: 34064340]
[17]
Okabe H, Hui S-P, Fuda H, Furukawa T, Takeda S, Shrestha R. Mass spectrometric quantification of amphipathic, polyphenolic antioxidant of the pacific oyster (Crassostrea gigas). Anal Sci 2015; 31(12): 1341-4.
[http://dx.doi.org/10.2116/analsci.31.1341] [PMID: 26656828]
[18]
Yamaguchi M, Yosiike K, Watanabe H, Watanabe M. The marine factor 3,5-dihydroxy-4-methoxybenzyl alcohol suppresses growth, migration and invasion and stimulates death of metastatic human prostate cancer cells: Targeting diverse signaling processes. Anticancer Drugs 2022; 33(5): 424-36.
[http://dx.doi.org/10.1097/CAD.0000000000001306] [PMID: 35324521]
[19]
Yamaguchi M, Weitzmann MN. Vitamin K2 stimulates osteoblastogenesis and suppresses osteoclastogenesis by suppressing NF-κB activation. Int J Mol Med 2011; 27(1): 3-14.
[http://dx.doi.org/10.3892/ijmm.2010.562] [PMID: 21072493]
[20]
Misawa H, Inagaki S, Yamaguchi M. Suppression of cell proliferation and deoxyribonucleic acid synthesis in the cloned rat hepatoma H4-II-E cells overexpressing regucalcin. J Cell Biochem 2002; 84(1): 143-9.
[http://dx.doi.org/10.1002/jcb.1274] [PMID: 11746523]
[21]
Yamaguchi M, Daimon Y. Overexpression of regucalcin suppresses cell proliferation in cloned rat hepatoma H4-II-E cells: Involvement of intracellular signaling factors and cell cycle-related genes. J Cell Biochem 2005; 95(6): 1169-77.
[http://dx.doi.org/10.1002/jcb.20490] [PMID: 15962315]
[22]
Izumi T, Yamaguchi M. Overexpression of regucalcin suppresses cell death in cloned rat hepatoma H4-II-E cells induced by tumor necrosis factor-? or thapsigargin. J Cell Biochem 2004; 92(2): 296-306.
[http://dx.doi.org/10.1002/jcb.20056] [PMID: 15108356]
[23]
Yamaguchi M, Osuka S, Weitzmann MN, El-Rayes BF, Shoji M, Murata T. Prolonged survival in pancreatic cancer patients with increased regucalcin gene expression: Overexpression of regucalcin suppresses the proliferation in human pancreatic cancer MIA PaCa-2 cells in vitro. Int J Oncol 2016; 48(5): 1955-64.
[http://dx.doi.org/10.3892/ijo.2016.3409] [PMID: 26935290]
[24]
Minkin C. Bone acid phosphatase: Tartrate-resistant acid phosphatase as a marker of osteoclast function. Calcif Tissue Int 1982; 34(1): 285-90.
[http://dx.doi.org/10.1007/BF02411252] [PMID: 6809291]
[25]
Pelech SL, Charest DL, Mordret GP, et al. Networking with mitogen-activated protein kinases. Mol Cell Biochem 1993; 127-128(1): 157-69.
[http://dx.doi.org/10.1007/BF01076767] [PMID: 7935348]
[26]
Yamaguchi M. Suppressive role of regucalcin in liver cell proliferation: Involvement in carcinogenesis. Cell Prolif 2013; 46(3): 243-53.
[http://dx.doi.org/10.1111/cpr.12036] [PMID: 23692083]
[27]
Woods M, Wood EG, Mitchell JA, Warner TD. Signal transduction pathways involved in cytokine stimulation of endothelin-1 release from human vascular smooth muscle cells. J Cardiovasc Pharmacol 2000; 36(5 (S1)): S407-9.
[http://dx.doi.org/10.1097/00005344-200036051-00119] [PMID: 11078435]
[28]
Echizen K, Hirose O, Maeda Y, Oshima M. Inflammation in gastric cancer: Interplay of the COX‐2/prostaglandin E2 and Toll‐like receptor/MyD88 pathways. Cancer Sci 2016; 107(4): 391-7.
[http://dx.doi.org/10.1111/cas.12901] [PMID: 27079437]
[29]
Guan F, Wang H, Shan Y, et al. Inhibition of COX-2 and PGE2 in LPS-stimulated RAW264.7 cells by lonimacranthoide VI, a chlorogenic acid ester saponin. Biomed Rep 2014; 2(5): 760-4.
[http://dx.doi.org/10.3892/br.2014.314] [PMID: 25054024]
[30]
Lin CC, Chan CM, Huang YP, Hsu SH, Huang CL, Tsai SJ. Methylglyoxal activates NF-κB nuclear translocation and induces COX-2 expression via a p38-dependent pathway in synovial cells. Life Sci 2016; 149: 25-33.
[http://dx.doi.org/10.1016/j.lfs.2016.02.060] [PMID: 26898122]
[31]
Fenton MJ, Golenbock DT. LPS-binding proteins and receptors. J Leukoc Biol 1998; 64: 25-32.
[32]
Nunes-Alves C. New LPS receptors discovered. Nat Rev Immunol 2014; 14(9): 583.
[http://dx.doi.org/10.1038/nri3736] [PMID: 25145754]
[33]
Huang MH, Lin YH, Lyu PC, et al. Imperatorin interferes with LPS binding to the TLR4 co-receptor and activates the Nrf2 antioxidative pathway in RAW264.7 murine macrophage cells. Antioxidants 2021; 10(3): 362.
[http://dx.doi.org/10.3390/antiox10030362] [PMID: 33673673]
[34]
Zhou C, Gao J, Ji H, et al. Modulates LPS-induced responses through inhibition of Toll-like receptor-mediated NF-κB and MAPK signaling in RAW264.7 cells. Inflammation 2021; 44(5): 2018-32.
[http://dx.doi.org/10.1007/s10753-021-01478-z] [PMID: 34272638]
[35]
Li N, Liu BW, Ren WZ, et al. GLP-2 attenuates LPS-induced inflammation in BV-2 cells by inhibiting ERK1/2, JNK1/2 and NF-κB signaling pathway. Int J Mol Sci 2016; 17(2): 190.
[http://dx.doi.org/10.3390/ijms17020190] [PMID: 26861286]
[36]
Cha SM, Cha JD, Jang EJ, Kim GU, Lee KY. Sophoraflavanone G prevents Streptococcus mutans surface antigen I/II-induced production of NO and PGE2 by inhibiting MAPK-mediated pathways in RAW 264.7 macrophages. Arch Oral Biol 2016; 68: 97-104.
[http://dx.doi.org/10.1016/j.archoralbio.2016.04.001] [PMID: 27111520]
[37]
Huang X, Fang J, Lai W, et al. IL-6/STAT3 axis activates glut5 to regulate fructose metabolism and tumorigenesis. Int J Biol Sci 2022; 18(9): 3668-75.
[http://dx.doi.org/10.7150/ijbs.68990] [PMID: 35813468]
[38]
Xiao Y, Cao Y, Song C, et al. Cellular study of the LPS‐induced osteoclastic multinucleated cell formation from RAW264.7 cells. J Cell Physiol 2020; 235(1): 421-8.
[http://dx.doi.org/10.1002/jcp.28982] [PMID: 31222739]
[39]
Liu Y, Fang S, Li X, et al. Aspirin inhibits LPS-induced macrophage activation via the NF-κB pathway. Sci Rep 2017; 7(1): 11549.
[http://dx.doi.org/10.1038/s41598-017-10720-4] [PMID: 28912509]
[40]
Sapkota M, Li L, Kim SW, Soh Y. Thymol inhibits RANKL-induced osteoclastogenesis in RAW264.7 and BMM cells and LPS-induced bone loss in mice. Food Chem Toxicol 2018; 120: 418-29.
[http://dx.doi.org/10.1016/j.fct.2018.07.032] [PMID: 30048646]

Rights & Permissions Print Cite
© 2024 Bentham Science Publishers | Privacy Policy